PWUP vs. KRRO, NMRA, YMAB, KOD, TVGN, NGNE, ACIU, HRTX, ELDN, and ITOS
Should you be buying PowerUp Acquisition stock or one of its competitors? The main competitors of PowerUp Acquisition include Korro Bio (KRRO), Neumora Therapeutics (NMRA), Y-mAbs Therapeutics (YMAB), Kodiak Sciences (KOD), Tevogen Bio (TVGN), Neurogene (NGNE), AC Immune (ACIU), Heron Therapeutics (HRTX), Eledon Pharmaceuticals (ELDN), and iTeos Therapeutics (ITOS). These companies are all part of the "pharmaceutical products" industry.
PowerUp Acquisition vs.
PowerUp Acquisition (NASDAQ:PWUP) and Korro Bio (NASDAQ:KRRO) are both small-cap unclassified companies, but which is the better stock? We will contrast the two companies based on the strength of their community ranking, dividends, earnings, valuation, institutional ownership, risk, analyst recommendations, media sentiment and profitability.
PowerUp Acquisition's return on equity of 0.00% beat Korro Bio's return on equity.
Korro Bio received 24 more outperform votes than PowerUp Acquisition when rated by MarketBeat users.
In the previous week, PowerUp Acquisition had 3 more articles in the media than Korro Bio. MarketBeat recorded 4 mentions for PowerUp Acquisition and 1 mentions for Korro Bio. Korro Bio's average media sentiment score of 0.00 beat PowerUp Acquisition's score of -0.07 indicating that Korro Bio is being referred to more favorably in the news media.
19.2% of PowerUp Acquisition shares are held by institutional investors. Comparatively, 13.2% of Korro Bio shares are held by institutional investors. 48.0% of PowerUp Acquisition shares are held by company insiders. Comparatively, 5.4% of Korro Bio shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
PowerUp Acquisition has a beta of 0.05, indicating that its stock price is 95% less volatile than the S&P 500. Comparatively, Korro Bio has a beta of 2.04, indicating that its stock price is 104% more volatile than the S&P 500.
Korro Bio has a consensus target price of $144.00, indicating a potential upside of 447.74%. Given Korro Bio's stronger consensus rating and higher possible upside, analysts plainly believe Korro Bio is more favorable than PowerUp Acquisition.
Summary
Korro Bio beats PowerUp Acquisition on 7 of the 12 factors compared between the two stocks.
Get PowerUp Acquisition News Delivered to You Automatically
Sign up to receive the latest news and ratings for PWUP and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
PowerUp Acquisition Competitors List
Related Companies and Tools
This page (NASDAQ:PWUP) was last updated on 2/21/2025 by MarketBeat.com Staff
Free PWUP Stock Alerts